{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:33:04Z","timestamp":1777386784108,"version":"3.51.4"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.crohns.2013.08.017","type":"journal-article","created":{"date-parts":[[2013,9,22]],"date-time":"2013-09-22T07:49:05Z","timestamp":1379836145000},"page":"282-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: A retrospective study"],"prefix":"10.1093","volume":"8","author":[{"given":"Mei Lan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Qi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang Han","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi Hua","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"4","key":"10.1016\/j.crohns.2013.08.017_bb0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00054725-200111000-00002","article-title":"Hepatitis B and C virus infection in Crohn's disease","volume":"7","author":"Biancone","year":"2001","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.crohns.2013.08.017_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2005.02556.x","article-title":"Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case\u2013control study","volume":"22","author":"Bargiggia","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.crohns.2013.08.017_bb0015","first-page":"77","article-title":"Prevalence of hepatitis C in patients with chronic inflammatory bowel disease in the region of Nice and evaluation of risk factors","volume":"24","author":"Longo","year":"2000","journal-title":"Gastroenterol Clin Biol"},{"issue":"2","key":"10.1016\/j.crohns.2013.08.017_bb0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.crohns.2012.03.001","article-title":"Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-alpha agents","volume":"7","author":"Papa","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"6","key":"10.1016\/j.crohns.2013.08.017_bb0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2036.2010.04570.x","article-title":"Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease","volume":"33","author":"Gisbert","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.017_bb0030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.crohns.2010.03.001","article-title":"Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature","volume":"4","author":"Katsanos","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"6","key":"10.1016\/j.crohns.2013.08.017_bb0035","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ibd.21147","article-title":"Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France","volume":"16","author":"Chevaux","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.017_bb0040","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.017_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10096-008-0628-x","article-title":"Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention","volume":"28","author":"Garcia-Vidal","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.crohns.2013.08.017_bb0050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.crohns.2013.08.017_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10620-005-1295-8","article-title":"Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B","volume":"50","author":"Ueno","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.crohns.2013.08.017_bb0060","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.20702","article-title":"Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection","volume":"51","author":"Parke","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.crohns.2013.08.017_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10067-006-0394-z","article-title":"Inhibition of TNFalpha does not induce viral reactivation in patients with chronic hepatitis C infection: two cases","volume":"26","author":"Aslanidis","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.crohns.2013.08.017_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.crohns.2013.08.017_bb0075","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0168-8278(03)00152-1","article-title":"Hepatitis B, vaccines","volume":"39","author":"Shouval","year":"2003","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.crohns.2013.08.017_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ajg.2008.4","article-title":"Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study","volume":"104","author":"Loras","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. A","key":"10.1016\/j.crohns.2013.08.017_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party o the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"6","key":"10.1016\/j.crohns.2013.08.017_bb0090","first-page":"592","article-title":"Seroprevalence of hepatitis B virus markers in individuals for physical examination in West China Hospital, China","volume":"15","author":"Wang","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"47","key":"10.1016\/j.crohns.2013.08.017_bb0095","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China\u2014declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.crohns.2013.08.017_bb0100","first-page":"888","article-title":"A sero-epidemiological study on hepatitis C in China","volume":"32","author":"Chen","year":"2011","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"20","key":"10.1016\/j.crohns.2013.08.017_bb0105","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3748\/wjg.14.3201","article-title":"Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementina Fraga Filho University Hospital","volume":"14","author":"Tolentino","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.crohns.2013.08.017_bb0110","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.crohns.2013.08.017_bb0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1470-2045(02)00773-8","article-title":"Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue","volume":"3","author":"Vento","year":"2002","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.crohns.2013.08.017_bb0120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/ard.62.7.686","article-title":"Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate","volume":"62","author":"Ostuni","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.crohns.2013.08.017_bb0125","first-page":"1624","article-title":"Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease","volume":"30","author":"Michel","year":"2003","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.crohns.2013.08.017_bb0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00054725-200409000-00035","article-title":"Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection","volume":"10","author":"del Valle Garc\u00eda-S\u00e1nchez","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.crohns.2013.08.017_bb0135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0609.2004.00375.x","article-title":"Hepatitis B virus reactivation and alemtuzumab therapy","volume":"74","author":"Iannitto","year":"2005","journal-title":"Eur J Haematol"},{"issue":"7","key":"10.1016\/j.crohns.2013.08.017_bb0140","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/10428190500062932","article-title":"Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations","volume":"46","author":"Law","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.017_bb0145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ibd.20035","article-title":"Occult hepatitis B and infliximab-induced HBV reactivation","volume":"13","author":"Madonia","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.crohns.2013.08.017_bb0150","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gut.2010.208413","article-title":"Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy","volume":"59","author":"Loras","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.crohns.2013.08.017_bb0155","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2008.01.023","article-title":"Occult hepatitis B virus in liver tissue of individuals without hepatic disease","volume":"48","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.crohns.2013.08.017_bb0160","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3324\/haematol.11224","article-title":"Italian blood donors with anti-HBc and occult hepatitis B virus infection","volume":"92","author":"Manzini","year":"2007","journal-title":"Haematologica"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613003103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613003103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/8\/4\/282\/1093234\/8-4-282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T18:00:21Z","timestamp":1503424821000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2013.08.017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1873994613003103"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2013.08.017","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2013.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}